Lipoprotein desialylation simultaneously enhances the cell cholesterol uptake and impairs the reverse cholesterol transport system: In vitro evidences utilizing neuraminidase-treated lipoproteins and mouse peritoneal macrophages

Atherosclerosis

Volumn 139, Issue 1, 1998, Pages 65-75

  Harada, Lila M ^a   Carvalho, Márcia D t ^a   Passarelli, Marisa ^a   Quintão, Eder C r ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atherosclerosis; Cholesterol efflux; Cholesteryl ester transfer protein (CETP); Desialylation; Lecithin:cholesterol acyltransferase (LCAT); Reverse cholesterol transport

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SIALIDASE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; ENZYME ACTIVITY; LIPID METABOLISM; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELLS, CULTURED; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; GLYCOPROTEINS; HUMANS; LIPOPROTEINS; MACROPHAGES, PERITONEAL; MICE; NEURAMINIDASE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; SIALIC ACIDS;

EID: 0032126274     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00057-4     Document Type: Article

References (67)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL Modifications of low-density lipoprotein that increase its atherogenecity. N Engl J Med. 320:1989;915-924.
2. Fogelman AM, Shechter I, Seager J, Hokom M, Child JS, Edwards PA Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte macrophages. Proc Natl Acad Sci USA. 77:1980;2214-2218.
3. Lopes-Virella MF, Klein RL, Lyons TJ, Stevenson HC, Witztum JL Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human-derived macrophages. Diabetes. 37:1988;550-557.
4. Goldstein JL, Ho HJK, Basu SK, Brown MS Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition. Proc Natl Acad Sci USA. 76:1979;333-337.
5. Palinski W, Rosenfeld ME, Y-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA. 86:1989;1372-1376.
6. Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes. 31:1982;283-291.
7. Hunt JV, Bottoms MA, Clare K, Skamarauskas JT, Mitchinson MJ Glucose oxidation and low-density lipoprotein-induced macrophages ceroid accumulation: possible implications for diabetes atherosclerosis. Biochem J. 300:1994;243-249.
8. Orekhov AN, Tertov VV, Mukhin DN Desialylated low density lipoproteins - naturally occurring modified lipoprotein with atherogenic potency. Atherosclerosis. 86:1991;153-161.
9. Tertov VV, Orekhov AN, Sobenin IA, Gabbasov ZA, Popov EG, Yaroslavov AA, Smirnov VN Three types of naturally occuring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation. Circ Res. 71:1992;218-228.
10. Swaminathan N, Aladjem F The monosaccharide composition and sequence of the carbohydrate moiety of human serum low density lipoproteins. Biochemistry. 15:1976;1516-1522.
11. Filipovic I, Buddecke E Desialyzed low-density lipoprotein regulates cholesterol metabolism in receptor-deficient fibroblasts. Eur J Biochem. 101:1979;119-122.
12. Gorog P, Born GVR Increased uptake of circulating low-density lipoproteins and fibrinogen by arterial walls after removal of sialic acids from their endotherial surface. Br J Exp Pathol. 63:1982;447-451.
13. Born GVR, Palinski W Unusually high concentrations of sialic acids on the surface of vascular endothelia. Br J Exp Pathol. 66:1985;543-549.
14. Attie AD, Weinstein DB, Freeze HH, Pittman RC, Steinberg GD Unaltered catabolism of desialylated low-density lipoprotein in the pig and in cultured rat hepatocytes. Biochem J. 180:1979;647-654.
15. Malmendier CE, Delcroix C, Fontaine M Effect of sialic acid removal in human low desnity lipoprotein catabolism in vivo. Atherosclerosis. 37:1980;227-284.
16. Orekhov AN, Tertov VV, Mukhin DN, Mikhailenko IA Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells. Biochem Biophys Res Commun. 162:1989;206-211.
17. Sobenin IA, Tertov VV, Koschinsky T, Bunting CE, Slavina ES, Dedov II, Orekhov AN Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells. Atherosclerosis. 100:1993;41-54.
18. Tertov VV, Sobenin IA, Tonevitsky AG, Orekhov AN, Smirnov VN Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography. Biochem Biophys Res Commun. 167:1990;1122-1127.
19. Orekhov AN, Tertov VV, Sobenin IA, Smirnov VN, Via DP, Guevara J, Gotto AM, Morrisett JD Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. J Lipid Res. 33:1992;805-817.
20. Tertov VV, Sobenin IA, Gabbasov ZA, Popov EG, Orekhov AN Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins. Biochem Biophys Res Commun. 163:1989;489-494.
21. Tertov VV, Sobenin IA, Orekhov AN, Jaakkola O, Solakivi T, Nikkari T Characteristics of low density lipoprotein isolated from circulating immune complexes. Atherosclerosis. 122:1996;191-199.
22. Orekhov AN, Tertov VV, Kabakov AE, Adamova IY, Pokrovsky SN, Smirnov VN Autoantibodies against modified low density lipoprotein. Nonlipid of blood plasma that stimulates foam cell formation. Arterioscler Thromb. 11:1991;316-326.
23. Lindberg G, Eklund GA, Gullberg B, Rastam L Serum sialic acid concentration and cardiovascular mortality. Br Med J. 302:1991;143-146.
24. Yokoyama H, Jensen JS, Jensen T, Deckert T Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephopathy. J Inter Med. 237:1995;519-523.
25. Fielding CJ, Fielding PE Molecular physiology of reverse cholesterol transport. J Lipid Res. 36:1995;211-228.
26. Johnson WJ, Mahlberg FH, Rothblat GH, Phillips MC Cholesterol transport between cells and high-density lipoproteins. Biochim Biophys Acta. 1085:1991;273-298.
27. Pieters MN, Schouten D, Van Berkel JC In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport. Biochim Biophys Acta. 1225:1994;125-134.
28. Quintao ECR Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation? Atherosclerosis. 116:1995;1-14.
29. Dobiasova M Lecithin:cholesterol acyltransferase and the regulation of endogenous cholesterol transport. Adv Lipids Res. 20:1983;107-194.
30. Jonas A Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins. Biochim Biophys Acta. 1084:1991;205-220.
31. Lagrost L Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochim Biophys Acta. 1215:1994;209-236.
32. Tall A Plasma lipid transfer proteins. Annu Rev Biochem. 64:1995;235-257.
33. Havel RJ, Eder HA, Gragdon JH The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 34:1955;1345-1353.
34. Warren L The thiobarbituric acid assay of sialic acids. J Biol Chem. 234:1959;1971-1975.
35. Bartlett G Phosphorus assay in column chromatography. J Biol Chem. 234:1958;466-468.
36. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
37. 2 and apo E-rich HDL1 in the rat: effects of lipid transfer protein. J Lipid Res. 28:1987;257-267.
38. Basu SK, Goldstein JL, Anderson RGW, Brown MS Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous hypercholesterolemia fibroblasts. Proc Natl Acad Sci USA. 73:1976;3178-3182.
39. 2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Acad Natl Sci USA. 82:1985;3000-3004.
40. Noble RP Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res. 9:1968;693-700.
41. Hara H, Yokoyama S Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J Biol Chem. 266:1991;3080-3086.
42. Brown MS, Ho YK, Goldstein JL The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. J Biol Chem. 255:1980;9344-9352.
43. La Ville AE, Sola R, Balanya J, Turner PR, Masana L In vitro oxidised HDL is recognised by the scavenger receptor of macrophages: implications for its protective role in vivo. Biochem Biophys Acta. 105:1994;179-189.
44. 3 subclasses: study in hypertensive and normal middle-aged and septuagenarian men. J Lipid Res. 33:1992;1411-1418.
45. Goldstein JL, Basu SK, Brown MS Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98:1983;241-2260.
46. Guérin M, Dolphin PJ, Chapman MJ A new in vitro method for the simultaneous evaluation of cholesteryl ester exchange and mass transfer between HDL and apo B-containing lipoprotein subspecies. Identification of preferential cholesteryl ester acceptors in human plasma. Arterioscler Thromb. 14:1994;199-206.
47. Bachorik PS, Albers J Precipitation methods for quantification of lipoprotein. Methods Enzymol. 129:1986;78-100.
48. Nagano Y, Arai H, Kita T High density lipoprotein loses its effect of stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci USA. 88:1991;6457-6461.
49. Rifici VA, Khachadurian AK Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages. Biochim Biophys Acta. 1299:1996;87-95.
50. Barrans A, Jaspard B, Barbaras R, Chap H, Perret B, Collet X Pre-b HDL: structure and metabolism. Biochim Biophys Acta. 1300:1996;73-85.
51. Oram JF, Albers JJ, Cheung MC, Bierman EL The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity. J Biol Chem. 256:1981;8348-8356.
52. Francone OL, Haghpassand M, Bennett JA, Royer L, McNeish J Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport. J Lipid Res. 38:1997;813-822.
53. Czarnecka H, Yokoyama S Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux. Biochemistry. 34:1995;4385-4392.
54. Fielding CJ, Fielding PE Evidence for a lipoprotein carrier in human plasma catalyzing sterol efflux from cultured fibroblasts and its relationship to lecithin:cholesterol acyltransferase. Proc Natl Acad Sci USA. 78:1981;3911-3914.
55. Francone OL, Gurakar A, Fielding C Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. J Biol Chem. 264:1989;7066-7072.
56. Passarelli M, Catanozi S, Nakandakare ER, Rocha JC, Morton RE, Shimabukuro AFM, Quintao ECR Plasma lipoproteins from diabetes with poorly controlled diabetes mellitus and in vitro glycation of lipoproteins enhance the transfer rate of cholesteryl ester from HDL to apo B-containing lipoproteins. Diabetologia. 40:1997;1085-1093.
57. Nishida HI, Arai H, Nishida T Cholesterol ester transfer mediated by lipid transfer protein as influenced by changes in the charge characteristics of plasma lipoproteins. J Biol Chem. 268:1993;16352-16360.
58. Pattnaik NM, Zilversmit D Interaction of cholesteryl ester exchange protein with human plasma lipoproteins and phospholipid vesicles. J Biol Chem. 254:1979;2782-2786.
59. Sammett D, Tall AR Mechanism of enhancement of cholesteryl ester transfer protein activity by lipolysis. J Biol Chem. 260:1985;6687-6697.
60. Lagrost L, Barter PJ Effect of various non-esterified fatty acids on the transfer of cholesteryl esters from HDL to LDL induced by the cholesteryl ester transfer protein. Biochim Biophys Acta. 1085:1991;209-216.
61. Tertov VV, Sobenin IA, Gabbasov ZA, Popov EG, Jaakkola O, Solakivi T, Nikkari T, Smirnov VN, Orekhov AN Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization. Lab Invest. 67:1992;665-675.
62. Grewal T, Bartlett A, Burgess JW, Packer NH, Stanley KK Desialylated LDL uptake in human and mouse macrophages can be mediated by a lectin receptor. Atherosclerosis. 121:1996;151-163.
63. Murakami M, Horiuchi S, Takata K, Morino Y Distinction in the mode of receptor-mediated endocytosis between high density lipoprotein and acetylated high density lipoprotein: evidence fot high density lipoprotein receptor-mediated cholesterol transfer. J Biochem. 101:1987;729-741.
64. Miyazaki A, Sakai M, Yamaguchi E, Sakamoto YI, Shichiri M, Horiuchi S Two independent macrophage receptors for acetylated high-density lipoprotein. Biochem Biophys Acta. 1170:1993;143-150.
65. Rahim ATMA, Miyazaki A, Morino Y, Horiuchi S Biochemical demonstration of endocytosis and subsequent resecretion of high-density lipoprotein by rat peritoneal macrophages. Biochim Biophys Acta. 1082:1991;195-203.
66. Schmitz G, Robenek H, Lohmann U, Assmann G Interaction of high density lipoproteins with cholesteryl ester-laden macrophages: biochemical and morphological characterization of cell surface receptor binding, endocytosis and resecretion of high density lipoprotein by macrophages. EMBO J. 4:1985;613-622.
67. Miyazaki A, Rahim ATMA, Ohta T, Morino Y, Horiuchi S High density lipoprotein mediates selective reduction in cholesteryl esters from macrophages foam cells. Biochem Biophys Acta. 1126:1992;73-80.